Table 1.
Tumor (corresponding to Figure 4) dosimetric characteristics resulting from predictive treatment planning. For mediastinal tumors, the D95 and mean dose difference between PTVpred and PTVresd averaged 3.4 Gy and 1.1 Gy, slightly higher compared to that of 2.9 Gy and 0.9 Gy for parenchymal tumors.
| PTVori D95 Gy | PTVpred D95 Gy | PTVresd D95 Gy | PTVpred Dmean Gy | PTVresd Dmean Gy | |
|---|---|---|---|---|---|
| mediastinal tumors | |||||
| 1 | 59.5 | 70.6 | 67.7 | 73.9 | 73.1 |
| 2 | 70.9 | 79.5 | 76.6 | 84.2 | 83.0 |
| 3 | 70.7 | 79.3 | 76.1 | 81.4 | 80.4 |
| 4 | 60.0 | 70.3 | 65.5 | 73.0 | 71.7 |
| 5 | 61.0 | 69.6 | 66.4 | 73.4 | 72.2 |
| 6 | 61.5 | 70.4 | 66.7 | 73.9 | 72.9 |
| parenchymal tumors | |||||
| 7 | 70.0 | 76.2 | 74.4 | 78.5 | 78.0 |
| 8 | 60.3 | 67.8 | 67.8 | 71.8 | 71.8 |
| 9 | 57.0 | 64.3 | 63.3 | 65.6 | 65.4 |
| 10 | 70.3 | 87.5 | 81.6 | 91.4 | 89.7 |
| 11 | 61.5 | 70.5 | 68.9 | 74.4 | 73.8 |
| 12 | 70.0 | 78.5 | 75.5 | 82.5 | 81.4 |